Use of glycopeptides was highest in DSTA patients (74.1%), use of penicillins, particularly those combined with beta-lactamase inhibitors, was highest in DFI patients (50.4%), and use of cephalosporins, particularly first-generation agents, was higher in SSI (11.2%) and cellulitis (13.3%) patients than in others. Here, LACTB is linked to cellulitis.